Literature DB >> 11221511

Thin melanomas.

R King1, P B Googe, M C Mihm.   

Abstract

Thin melanoma refers to that grouping of melanomas that statistically have a good prognosis and survival rate. A small but significant percentage of these lesions metastasize and cause mortality. Histologically, these lesions comprise a diverse grouping of tumors of any intraepidermal growth pattern; in the radial or vertical growth phase; or in anatomic level I, II, III, or IV. Additional histologic findings may also be variably present, such as regression, tumor infiltrating lymphocytes, and mitoses. Molecular studies suggest that thin melanomas may have different properties to thicker and metastatic melanomas. The factors governing the ability of thin melanomas to metastasize and cause mortality are not known. Certain histologic and molecular parameters, some of which have been alluded to previously, may provide clues to understanding the parameters governing the aggressive nature of some of these lesions. Further research is required to enhance our understanding of thin melanomas.

Entities:  

Mesh:

Year:  2000        PMID: 11221511

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  3 in total

1.  Nano-characterization of two closely related melanoma cell lines with different metastatic potential.

Authors:  Justyna Gostek; Szymon Prauzner-Bechcicki; Benedikt Nimmervoll; Katrin Mayr; Joanna Pabijan; Peter Hinterdorfer; Lilia A Chtcheglova; Małgorzata Lekka
Journal:  Eur Biophys J       Date:  2014-12-04       Impact factor: 1.733

2.  Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials.

Authors:  Uma N M Rao; Sandra J Lee; Weixiu Luo; Martin C Mihm; John M Kirkwood
Journal:  Am J Clin Pathol       Date:  2010-04       Impact factor: 2.493

3.  CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.

Authors:  Carlos Monteagudo; David Ramos; Ana Pellín-Carcelén; Rosario Gil; Robert C Callaghan; José M Martín; Vicent Alonso; Amelia Murgui; Lara Navarro; Silvia Calabuig; José Antonio López-Guerrero; Esperanza Jordá; Antonio Pellín
Journal:  Clin Exp Metastasis       Date:  2012-04-21       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.